BONU Ygiene Brand To Be Acquired By Major Players? Read Inside.
July 16th, 2009 at 3:13 pm Posted by The Dean
It’s not very often that you can become a partial owner in an undervalued brand name that could potentially revolutionize the already lucrative market for antibacterial hand sanitizers (think Purell) in a very big way. But right now and with a market cap of less than $20 million you can own shares of BONU ($0.29) and be part of an exciting new trend in the consumer market.
BONU is the only player in the hand sanitizers market whose product (Ygiene) has the ability to kill Anthrax in addition to 99.97% of all human germs.
If its one thing I’m certain of: its that companies like Johnson & Johnson (JNJ) would pay a lot more than $20 million for a Purell-like product that also kills potentially life threatening bio-terrorism microorganisms like Black Mold and Anthrax!
The Dean is not a fortune teller, but one thing he can predict is that thousands of new investors will learn all about BONU this coming weekend.
*The Dean has been compensated fifteen thousand dollars by a 3rd party (546 Holdings, Ltd) for business development and corporate communications services related to Bioneutral (BONU). For The Dean’s full disclaimer click HERE.
BONU is provoking my nerves and I am very enthusiastic about it. The opportunity is in my hand.
Ever wondered why BONU can make you get a nice hunk of change? It is the only sanitizer which can kill anthrax along with germs.
BONU is the kind of player I have been looking out for. It offers Ygiene which every individual will certainly opt for day by day.